● Recruiting

T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas

Condition: Malignant Glioma · Sponsor: John M. Buatti

PhaseNA

Planned participants15

Who can joinAll sexes, 21 Years to no upper limit

Healthy volunteersNo

About this study

This clinical trial studies whether T2 star (T2\*) magnetic resonance imaging (MRI) and biomarker blood testing can help predict how World Health Organization (WHO) grade IV gliomas (malignant gliomas) might change or progress over time.

This description comes directly from the study's public registry record.

Talk to the study team

John Buatti, MD · (319) 356-7590 · john-buatti@uiowa.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Iowa Health Care

Iowa City, Iowa, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07447531